Covered recipient · General Payments record
MALEHA HUSAIN
Allopathic & Osteopathic Physicians Internal Medicine
General Payments · PY2018
$194.39
- Reported across 16 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2018 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $194.39 | 16 |
By paying entity
PY2018 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Novo Nordisk AS | $105.19 | 9 |
| Amgen Inc. | $35.05 | 3 |
| NOVARTIS PHARMACEUTICALS CORPORATION | $16.37 | 1 |
| SANOFI-AVENTIS U.S. LLC | $14.93 | 1 |
| PFIZER INC. | $11.72 | 1 |
| Astellas Pharma US Inc | $11.13 | 1 |
By program year
All program years on this page · sorted by year
| Program year | Amount | Records |
|---|---|---|
| PY2018 | $194.39 | 16 |
Payment records · PY2018 (16)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Amgen Inc. | $11.73 | 01/18/2018 | Food and Beverage | Undisputed | 01/23/2026 | 567602101 | CMS |
| Amgen Inc. | $10.84 | 03/06/2018 | Food and Beverage | Undisputed | 01/23/2026 | 567602097 | CMS |
| Amgen Inc. | $12.48 | 04/19/2018 | Food and Beverage | Undisputed | 01/23/2026 | 567602099 | CMS |
| Astellas Pharma US Inc | $11.13 | 08/08/2018 | Food and Beverage | Undisputed | 01/23/2026 | 582711221 | CMS |
| Novartis Pharmaceuticals Corporation | $16.37 | 01/09/2018 | Food and Beverage | Undisputed | 01/23/2026 | 608286155 | CMS |
| Novo Nordisk Inc | $12.91 | 02/21/2018 | Food and Beverage | Undisputed | 01/23/2026 | 587932727 | CMS |
| Novo Nordisk Inc | $1.46 | 02/21/2018 | Food and Beverage | Undisputed | 01/23/2026 | 587932729 | CMS |
| Novo Nordisk Inc | $14.28 | 03/13/2018 | Food and Beverage | Undisputed | 01/23/2026 | 587932735 | CMS |
| Novo Nordisk Inc | $14.43 | 04/23/2018 | Food and Beverage | Undisputed | 01/23/2026 | 587932723 | CMS |
| Novo Nordisk Inc | $13.69 | 05/09/2018 | Food and Beverage | Undisputed | 01/23/2026 | 587932725 | CMS |
| Novo Nordisk Inc | $13.33 | 05/15/2018 | Food and Beverage | Undisputed | 01/23/2026 | 587932733 | CMS |
| Novo Nordisk Inc | $12.33 | 06/05/2018 | Food and Beverage | Undisputed | 01/23/2026 | 587932739 | CMS |
| Novo Nordisk Inc | $9.97 | 06/18/2018 | Food and Beverage | Undisputed | 01/23/2026 | 587932737 | CMS |
| Novo Nordisk Inc | $12.79 | 07/24/2018 | Food and Beverage | Undisputed | 01/23/2026 | 587932731 | CMS |
| PFIZER INC. | $11.72 | 04/04/2018 | Food and Beverage | Undisputed | 01/23/2026 | 610247665 | CMS |
| SANOFI-AVENTIS U.S. LLC | $14.93 | 05/29/2018 | Food and Beverage | Undisputed | 01/23/2026 | 602330705 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018
- Source files
- Dataset page · Bulk file · PY2018
- Generated from
- OP_DTL_GNRL_PGYR2018_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.